A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

NCT04289987 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

BIOLOGICAL: CVI-HBV-002
BIOLOGICAL: Normal Saline(placebo)

Sponsor

CHA Vaccine Institute Co., Ltd.